- Home
- NIE vs CRMD Comparison
NIE vs CRMD Comparison
Compare NIE & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIE
- CRMD
- Stock Information
- Founded
- NIE 2007
- CRMD 2006
- Country
- NIE United States
- CRMD United States
- Employees
- NIE N/A
- CRMD N/A
- Industry
- NIE Investment Managers
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- NIE Finance
- CRMD Health Care
- Exchange
- NIE Nasdaq
- CRMD Nasdaq
- Market Cap
- NIE 612.1M
- CRMD 626.8M
- IPO Year
- NIE N/A
- CRMD 2010
- Fundamental
- Price
- NIE $23.70
- CRMD $10.33
- Analyst Decision
- NIE
- CRMD Strong Buy
- Analyst Count
- NIE 0
- CRMD 5
- Target Price
- NIE N/A
- CRMD $15.20
- AVG Volume (30 Days)
- NIE 70.5K
- CRMD 1.7M
- Earning Date
- NIE 01-01-0001
- CRMD 10-30-2024
- Dividend Yield
- NIE 9.04%
- CRMD N/A
- EPS Growth
- NIE N/A
- CRMD N/A
- EPS
- NIE N/A
- CRMD N/A
- Revenue
- NIE N/A
- CRMD $12,262,234.00
- Revenue This Year
- NIE N/A
- CRMD N/A
- Revenue Next Year
- NIE N/A
- CRMD $277.75
- P/E Ratio
- NIE N/A
- CRMD N/A
- Revenue Growth
- NIE N/A
- CRMD 41184.20
- 52 Week Low
- NIE $18.61
- CRMD $2.89
- 52 Week High
- NIE $22.47
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- NIE 58.00
- CRMD 47.62
- Support Level
- NIE $22.89
- CRMD $11.27
- Resistance Level
- NIE $24.21
- CRMD $12.40
- Average True Range (ATR)
- NIE 0.27
- CRMD 0.89
- MACD
- NIE 0.05
- CRMD -0.17
- Stochastic Oscillator
- NIE 61.36
- CRMD 20.90
About NIE Virtus Equity & Convertible Income Fund of Beneficial Interest
Virtus AllianzGI Equity & Convertible Income Fund is a diversified, closed-end management investment company. Its investment objective is to seek total return comprised of capital appreciation, current income, and gains. The fund pursues its objective by investing in a diversified portfolio of equity securities and income-producing convertible securities. Its portfolio of investments comprises different sector investments such as aerospace and defense, banks, IT services, software, and others.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.